Mosaic Company (The) · Earnings release

The Mosaic Company

www.mosaicco.com

For Immediate Release

Investors

Joan Tong

joan.tong@mosaicco.com

Jason Tremblay

jason.tremblay@mosaicco.com

Media

Ben Pratt

benjamin.pratt@mosaicco.com

THE MOSAIC COMPANY REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS

•Full year 2025 net income of $541 million. Fourth quarter net loss of $519 million was negatively impacted by several notable items.

•Full year 2025 adjusted EBITDA(1) was $2.4 billion. Fourth quarter adjusted EBITDA(1) of $505 million was impacted by weak U.S. demand.

•Fourth quarter phosphate production totaled 1.7 million tonnes, with improved performance continuing into early 2026. First quarter phosphate sales volumes are expected to recover sequentially to 1.7 to 1.9 million tonnes.

•2025 potash production totaled 8.8 million tonnes, with MOP output reaching its highest level since 2019. Esterhazy delivered its strongest finished product production since 2022, and Belle Plaine set a new record.

•Mosaic Fertilizantes operating earnings of $277 million in 2025 up 16% and adjusted EBITDA(1) of $567 million up 65% versus the prior year.

•Mosaic Biosciences contributed positively to fourth quarter adjusted EBITDA. 2025 net sales more than doubled to $68 million, and net sales are targeted to double again in 2026.

TAMPA, FL, February 24, 2026 - The Mosaic Company (NYSE: MOS) reported net income of $541 million and diluted earnings per share (EPS) of $1.70 for full year 2025. Adjusted EBITDA(1) was $2.4 billion and adjusted diluted EPS(1) was $2.27.

The company reported fourth quarter net loss of $519 million and diluted EPS of $(1.64). Adjusted EBITDA(1) totaled $505 million for the quarter and adjusted diluted EPS(1) was $0.22.

"Mosaic made significant progress in 2025. We fortified our assets to ensure reliable production, delivered meaningful cost and efficiency progress and divested non-core assets,” said President and CEO Bruce Bodine. “Deferred demand and higher raw material costs negatively impacted our year end results, but demand is expected to recover as we move toward the planting season."

(1)See “Non-GAAP Financial Measures” for additional information and reconciliation.

1

Consolidated Results:

In millions $ except as noted below

Net Sales (Billions)

Selling, General and Administrative expenses

Operating Earnings (Loss)

Operating Earnings (Loss) – Phosphate

Operating Earnings (Loss) – Potash

Operating Earnings (Loss) – Mosaic Fertilizantes

Operating Earnings (Loss) – Corporate and Other

Net Income (Loss)

Adjusted EBITDA(1)

Adjusted EBITDA - Phosphate(1)

Adjusted EBITDA - Potash(1)

Adjusted EBITDA – Mosaic Fertilizantes(1)

Adjusted EBITDA – Corporate and Other(1)

The fourth quarter net loss of $519 million reflected $422 million in pre-tax notable items which includes a $189 million impairment related to the Carlsbad asset held for sale, $110 million of goodwill and fixed asset impairments in Mosaic Fertilizantes and $223 million of various other items including foreign currency losses, mark-to-market adjustments, and asset retirement obligations. These impacts were partially offset by a gain of $100 million related to asset sales in Mosaic Fertilizantes, including a $94 million gain from the Patos de Minas transaction. Fourth quarter earnings were also impacted by a $261 million after-tax reserve on deferred tax assets in Mosaic Fertilizantes.

Net income in 2025 was $541 million, compared with $175 million in the prior year. Adjusted EBITDA(1) in 2025 totaled $2.4 billion, an increase of 10 percent from 2024, driven by higher prices and sales volumes in the Potash segment, margin expansion in the Mosaic Fertilizantes segment, and improved margins in India and China within the Corporate segment. These positive drivers were partially offset by lower sales volumes in the Phosphate segment.

In 2025, the Company achieved its $150 million value capture target versus 2023 and G1expanded the program to target an additional $100 million in 2026 versus 2025. Approximately $100 million of the value capture achieved in 2025 was captured in Mosaic Fertilizantes through lower blended rock cost, higher co-product sales, and reduced scrap products.

Selling, general and administrative (SG&A) expenses were $534 million for full year 2025, up from $497 million in the prior year. The increase was primarily due to increased selling expenses in Mosaic Biosciences, increased employee benefit costs, and noncash amortization related to the Global Digital Acceleration project, partially offset by productivity improvements.

The effective tax rate for full year 2025 was 52.7% percent. The adjusted effective tax rate(1) was 30.8% percent excluding net unfavorable impacts from notable items. Cash taxes paid were $321 million for 2025.

Cash flow from operations was $825 million for 2025 versus $1.3 billion in 2024. The year over year decline primarily reflects higher balance sheet working capital, driven by a $428 million increase in finished product inventories, and $346 million related to higher phosphate rock volumes and sulfur prices. Due to weak demand, the inventory build accelerated in the fourth quarter resulting in cash flow from operations of $(56) million.

(1)See “Non-GAAP Financial Measures” for additional information and reconciliation.

2

Capital expenditures for 2025 were $1.36 billion, up from $1.25 billion in 2024 driven primarily by higher spending to restore phosphate asset health and production reliability. Mosaic expects 2026 capital expenditures to be approximately $1.5 billion, reflecting higher spending for gypstack and clay settling areas. The increase is expected to be partially offset by lower cash spending on asset retirement obligations (ARO) and environmental reserves which are expected to decline from $408 million in 2025 to approximately $350 million in 2026.

Free cash flow(1) was $(535) million in 2025, compared to $47 million in 2024, driven by the factors outlined above.

Asset sales announced in 2025 are expected to yield total consideration of approximately $230 million, including approximately $170 million of cash payments over time, and the reduction of $60 million of ARO. This is in addition to further meaningful annual capital expenditure avoidance.

Mosaic paid a regular common dividend of $0.22 per share in the fourth quarter, returning $70 million to shareholders, with a total of $280 million returned to shareholders through dividends in 2025.

Potash:

In millions $ except as noted below

Net Sales (Billions)

Sales Volumes - million tonnes*

MOP Selling Price FOB mine

MOP Cash Cost of Production per tonne(1)

Gross Margin per tonne

Operating Earnings

Segment Adjusted EBITDA(1)

*Tonnes = finished product tonnes

The Potash segment reported net sales of $2.7 billion in 2025, up from $2.4 billion in 2024, reflecting higher prices and sales volumes. Operating earnings were $638 million, up from $604 million. Adjusted EBITDA(1) was $1.2 billion, up from $944 million in 2024, reflecting higher sales volume and prices.

Fourth quarter 2025 operating earnings were $58 million, down from $123 million in the prior-year period. Adjusted EBITDA(1) was $336 million, up from $212 million in the prior-year period, driven primarily by higher prices.

Potash production volumes were 8.8 million tonnes in 2025. Fourth quarter potash production volumes of 2.2 million tonnes reflected the temporary idling of operations at Esterhazy as a result of the previously reported fatality in early-December. In 2026, Mosaic expects total potash production of approximately 9 million tonnes, supported by record production at the Esterhazy site, which is expected to more than offset the volume impact of the Carlsbad divestiture.

MOP cash cost of production per tonne(1) was $75 in full year 2025, up from $71 in 2024, primarily reflecting a higher contribution of volumes produced at Colonsay.

First quarter of 2026 sales volumes are expected to be in the range of 2.0 and 2.2 million tonnes, with realized mine gate MOP prices in the range of $255 to $275 per tonne.

(1)See “Non-GAAP Financial Measures” for additional information and reconciliation.

3

Phosphates:

In millions $ except as noted below

Net Sales (Billions)

Sales Volumes - million tonnes*

DAP Selling Price FOB plant

Phosphate Cash Cost of Conversion per tonne(1)

Blended Rock Cost Consumed in COGS per tonne(1)

Gross Margin per tonne

Operating Earnings (Loss)

Segment Adjusted EBITDA(1)

*Tonnes = finished product tonnes

The Phosphate segment reported net sales of $4.6 billion in 2025, up from $4.5 billion in the prior year, reflecting higher prices and offset by slightly lower sales volumes. Operating earnings were $135 million, down from $225 million in the prior year. Adjusted EBITDA(1) was $917 million, compared to $1.2 billion in 2024, reflecting higher cash cost of conversion and increased idle and turnaround expenses, partially offset primarily by higher stripping margins and lower blended rock cost.

Fourth quarter 2025 operating loss totaled $98 million, compared with operating profit of $44 million from the same period prior year. Fourth quarter adjusted EBITDA(1) was $144 million, down from $341 million in the prior year period, reflecting lower sales volumes, higher raw material costs, and higher idle and turnaround expenses.

Lower sales volumes in the fourth quarter were primarily driven by lower U.S. phosphate demand amid affordability challenges. As a result, Mosaic ended the quarter with finished product inventories above prior periods. Mosaic expects first quarter sales volumes of 1.7 to 1.9 million tonnes with DAP prices averaging $640 to $670 per tonne on an FOB basis, reflecting strong international demand and an expected recovery in U.S. purchases ahead of spring planting.

Sulfur costs in cost of goods sold averaged $306 per tonne in the fourth quarter. Benchmark sulfur prices rose above $500 per tonne late in the fourth quarter, impacting the value of raw material inventory. Mosaic expects the full impact of higher sulfur prices to be reflected in cost of goods sold in the second quarter. Each $10 per tonne increase in sulfur costs is estimated to reduce quarterly EBITDA by approximately $10 million.

Idle and turnaround expenses in the fourth quarter reflected planned work at the Bartow site and the Faustina ammonia plant. The work on the Faustina ammonia plant is expected to support an over 50% increase in ammonia production in 2026 from a low level in 2025, enhancing Mosaic's cost position and competitiveness.

Production volumes were 6.3 million tonnes in 2025, largely unchanged from 2024. Fourth quarter production volumes were 1.7 million tonnes, compared with 1.4 million tonnes in the prior-year quarter, as Mosaic benefited from initiatives to normalize production. During the quarter, market dynamics drove production mix decisions towards products with higher phosphoric acid content, resulting in flat end-product volumes compared to the third quarter.

Cash cost of conversion per tonne(1) was $125 in 2025, up from $107 per tonne in 2024, reflecting higher maintenance and repair costs and increased down time as Mosaic focused on improving phosphate asset reliability. Cash cost of conversion per tonne(1) was $112 in the fourth quarter, declining meaningfully from elevated levels earlier in 2025, and is expected to continue to normalize in 2026.

2026 production volumes are expected to be at or above 7.0 million tonnes, assuming a normal product mix and reflecting recent operating run rates. Mosaic’s continued focus on better execution provides upside potential beyond this baseline.

(1)See “Non-GAAP Financial Measures” for additional information and reconciliation.

4

Mosaic Fertilizantes:

In millions $ except as noted below

Net Sales (Billions)

Sales Volumes - million tonnes*

Sales Volumes of produced product – million tonnes(3)

Average Finished Product Selling Price

Phosphate Cash Cost of Conversion per tonne(1)

Phosphate Blended Rock Cost Consumed in COGS per tonne

Gross Margin per tonne

Operating Earnings

Segment Adjusted EBITDA(1)

*Tonnes = finished product tonnes

(2)Represents volumes produced in Brazil and sold directly to third parties or through distribution.

The Mosaic Fertilizantes segment reported net sales of $4.8 billion in 2025, up from $4.4 billion, reflecting higher prices. Operating earnings were $277 million, up from $238 million in the prior year. Adjusted EBITDA(1) was $567 million, compared to $344 million in 2024, reflecting higher prices and improved operating margins.

Fourth quarter 2025 operating loss was $26 million, compared with an operating profit of $79 million in the prior year period, primarily due to a goodwill impairment. Segment gross margin per tonne declined to $10 per tonne, from $46 per tonne in the prior year, and adjusted EBITDA(1) to $45 million, from $82 million in the prior year period. Fourth quarter results were impacted by reduced sales volumes and distribution margin per tonne. The results also reflected lower production margins driven by a larger contribution of SSP sales, higher sulfur costs, and higher idle and turnaround expenses at Uberaba.

Full year sales volumes were 9.0 million tonnes, consistent with the prior year. Fourth-quarter sales volumes and distribution margin per tonne were impacted by intensified competition and tightening credit conditions. Mosaic has continued to adopt prudent risk management practices and prioritize sales to customers with strong credit profiles. Despite the challenging credit environment, Mosaic's market share remained steady in the Brazil fertilizer market in 2025.

Higher sulfur prices and a demand-driven shift toward lower-margin SSP products impacted the fourth quarter results. A sharp increase in sulfur prices late in the quarter, absent mitigating actions could materially impact production margins in 2026. In response, Mosaic temporarily curtailed SSP production at the Fospar JV and Araxa site, which together account for approximately 30% of Mosaic's production in Brazil. Mosaic continues to assess production plans as sulfur market conditions evolve.

Mosaic Fertilizantes phosphate cash cost of conversion per tonne(1) in 2025 was $95, slightly above the prior year of $94. Phosphate blended rock cost per tonne decreased to $97 in 2025, from $109 in the prior year, driven by higher volumes and reduced usage of higher cost imported rock.

First quarter sales volumes are expected to be below prior year levels, reflecting ongoing credit challenge and SSP production curtailment. Distribution margins per tonne are expected to be below the normal annualized $30-$40 range, reflecting typical seasonality. Production margins are expected to be below prior year levels due to higher sulfur costs and idle and turnaround expenses related to the SSP production curtailment. As a result, G2first quarter segment adjusted EBITDA is expected to be below $50 million.

(1)See “Non-GAAP Financial Measures” for additional information and reconciliation.

5

Mosaic Biosciences Update

Mosaic Biosciences launched five new products(3) and net sales more than doubled to $68 million compared to the prior year. The business positively contributed to fourth quarter adjusted EBITDA. In 2026, Mosaic Biosciences expects to launch eight to ten new products and targets net sales to approximately double compared with 2025.

Agriculture Market and Macroeconomic Update

Ag commodity prices are generally stable, with outlooks for another sizable Brazilian soybean crop and North America planting expectation indicating a further shift toward corn acreage. Growers are expected to replenish nutrients removed by last year's strong crop, and additional government support payments are poised to support demand for the North American spring application period.

Plant Nutrient Market Update

Despite a slow fourth quarter, 2026 is poised to be more constructive, with momentum building as North America spring season approaches. Similar interest is expected in the upcoming application seasons in India, Brazil, and China. Prices have already responded positively to global demand since the start of the year.

Phosphate markets have tightened as China exports remain largely absent following the announcement of extended phosphate export restrictions, which are expected to remain in place through at least the first half of the year. Mosaic is fielding demand inquiries from destinations historically served by Chinese suppliers. Additionally, elevated sulfur prices have contributed to phosphate production curtailments in China and Brazil which may further tighten phosphate markets.

Potash markets are balanced, and China's early contract settlement is expected to provide greater price stability and supports a positive outlook for Canpotex. Like phosphate, potash prices have shifted higher, and current expectations suggest global shipments could reach record levels in 2026.

In Brazil, credit constraints persist but expanding planted acreage and strong crop yields are expected to support fertilizer demand in 2026 as growers rebuild soil nutrients. Importantly, the recent surge of low-analysis phosphate imports from China is unlikely to recur given enhanced export restrictions.

Modeling Assumptions

G3Phosphate Production Volumes

At or above 7 million tonnes

G4Potash Production Volumes

Approximately 9 million tonnes

G5Total Capital Expenditures

Approximately $1.5 billion

G6Depreciation, Depletion & Amortization

G7Selling, General, and Administrative Expense

G8Net Interest Expense

Adjusted Effective Tax Rate

Low-to-Mid 30's%

Cash Tax Rate

Mid-to-High 20's%

Modeling Assumptions

G9Phosphate Sales Volumes (million tonnes)

DAP FOB Plant Prices

G10Potash Sales Volumes (million tonnes)

MOP FOB Mine Prices

(3) New products are defined as new brands or existing brands launched in new geographies.

6

Sensitivities Table

The Company provided the following sensitivities to help investors anticipate the potential impact of price movements in 2026.

Sensitivity

Full year adj. EBITDA impact(1)

Average MOP Price / tonne (fob mine)(4)

$10/mt price change = $65 million (4)

Average DAP Price / tonne (fob plant)

$10/mt price change = $80 million

(1)See “Non-GAAP Financial Measures” for additional information and reconciliation.

(4) Includes impact of Canadian Resource Tax

7

About The Mosaic Company

The Mosaic Company (NYSE: MOS) helps the world grow the food it needs. Headquartered in Tampa, Florida, Mosaic is a leading producer and marketer of potash and phosphate fertilizer which are essential inputs for the world’s farmers. Through the Mosaic Biosciences platform, the company is advancing the next generation of biological solutions designed to improve nutrient use efficiency, strengthen crop performance, and support more sustainable agricultural systems. As a Fortune 500 company with 13,000 employees serving customers in more than 40 countries, Mosaic is helping build resilient and productive food systems for the future. More information on the company is available at www.mosaicco.com.

Mosaic will conduct a conference call February 25, 2026, at 11:00 a.m. Eastern Time to discuss fourth quarter and full year 2025 earnings results. A simultaneous webcast of the conference call may be accessed through Mosaic’s website at www.mosaicco.com/investors. This webcast will be available up to one year from the time of the earnings call.

This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.

Such statements may include, but are not limited to, statements about future transactions or strategic plans and other statements

about future financial and operating results. Such statements are based upon the current beliefs and expectations of The Mosaic

Company’s management and are subject to significant risks and uncertainties. These risks and uncertainties include, but are not

limited to: political and economic instability and changes in government policies in countries in which we have operations; the

predictability and volatility of, and customer expectations about, agriculture, fertilizer, raw material, energy and transportation

markets that are subject to competitive and other pressures and economic and credit market conditions; the level of inventories

in the distribution channels for crop nutrients; the effect of future product innovations or development of new technologies on

demand for our products; changes in foreign currency and exchange rates; international trade risks, including the impact of U.S.

tariffs and retaliatory tariffs on economic conditions; and other risks associated with Mosaic’s international operations; a material

adverse change in our Ma'aden investment with respect to the financial position, performance, operations or prospects of

Ma'aden; customer defaults; the effects of Mosaic’s decisions to exit business operations or locations; changes in government

policy; changes in environmental and other governmental regulation, including expansion of the types and extent of water

resources regulated under federal law, carbon taxes or other greenhouse gas regulation, implementation of numeric water

quality standards for the discharge of nutrients into Florida waterways or efforts to reduce the flow of excess nutrients into the

Mississippi River basin, the Gulf of America or elsewhere; further developments in judicial or administrative proceedings, or

complaints that Mosaic’s operations are adversely impacting nearby farms, business operations or properties; difficulties or

delays in receiving, increased costs of or challenges to necessary governmental permits or approvals or increased financial

assurance requirements; resolution of global tax audit activity; the effectiveness of Mosaic’s processes for managing its strategic

priorities; adverse weather conditions affecting operations in Central Florida, the Mississippi River basin, the Gulf Coast of the

United States, Canada or Brazil, and including potential hurricanes, excess heat, cold, snow, rainfall or drought; actual costs of

various items differing from management’s current estimates, including, among others, asset retirement, environmental

remediation, reclamation or other environmental regulation, Canadian resources taxes and royalties, reduction of Mosaic’s

available cash and liquidity, and increased leverage, due to its use of cash and/or available debt capacity to fund financial

assurance requirements and strategic investments; brine inflows at Mosaic’s potash mines; other accidents and disruptions

involving Mosaic’s operations, including potential mine fires, floods, explosions, seismic events, sinkholes or releases of

hazardous or volatile chemicals; and risks associated with cyber security, including reputational loss; as well as other risks and

uncertainties reported from time to time in The Mosaic Company’s reports filed with the Securities and Exchange Commission.

Actual results may differ from those set forth in the forward-looking statements.

Non-GAAP Financial Measures

This press release includes the presentation and discussion of non-GAAP diluted net earnings per share, or adjusted EPS, non-GAAP adjusted EBITDA, non-GAAP cash cost of conversion or production per tonne, or non-GAAP adjusted effective tax rate and free cash flow, collectively referred to as non-GAAP financial measures. Generally, a non-GAAP financial measure is a supplemental numerical measure of a company's performance, financial position or cash flows that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented in accordance with U.S. generally accepted accounting principles, or GAAP. Non-GAAP financial measures should not be considered as substitutes for, or superior to, measures of financial performance prepared in accordance with GAAP.

In addition, because non-GAAP measures are not determined in accordance with GAAP, they are thus susceptible to varying interpretations and calculations and may not be comparable to other similarly titled measures of other companies. Adjusted metrics, including adjusted EPS, adjusted gross margin, and adjusted EBITDA are calculated by excluding the impact of notable items from the GAAP measure. Notable items impact on gross margin and adjusted EBITDA is pretax. Notable items impact on diluted net earnings per share is calculated as the notable item amount plus income tax effect, based on expected annual effective tax rate, divided by diluted weighted average shares. Free cash flow is defined as net cash provided by operating activities less capital expenditures.

Management believes that these adjusted measures provide securities analysts, investors, management and others with useful supplemental information regarding our performance by excluding certain items that may not be indicative of, or are unrelated to, our core operating results. Management utilizes these adjusted measures in analyzing and assessing Mosaic’s overall performance and financial trends, for financial and operating decision-making, and to forecast and plan for future periods. These adjusted measures also assist our management in comparing our and our competitors' operating results.

8

We are not providing forward looking guidance for U.S. GAAP reported diluted net earnings per share, gross margin per tonne, or a quantitative reconciliation of forward-looking adjusted EPS, adjusted gross margin and adjusted EBITDA because we are unable to predict with reasonable certainty our notable items without unreasonable effort. Historically, our notable items have included, but are not limited to, foreign currency transaction gain or loss, unrealized gain or loss on derivatives and equity securities, acquisition-related fees, discrete tax items, contingencies and certain other gains or losses. These items are uncertain, depend on various factors, and could have a material impact on U.S. GAAP reported results for the guidance period.

Reconciliations for Non-GAAP financial measures contained in this press release are found below. Reconciliations for current and historical periods beginning with the quarter ended March 31, 2024 for consolidated adjusted EPS and adjusted EBITDA, as well as segment adjusted EBITDA and adjusted gross margin per tonne are provided in the Selected Calendar Quarter Financial Information performance data for the related periods. This information is being furnished under Exhibit 99.2 of the Form 8-K and available on our website at www.mosaicco.com in the “Financial Information - Quarterly Earnings” section under the “Investors” tab.

9

For the three months ended December 31, 2025, the Company reported the following notable items which, combined, negatively impacted earnings per share by $1.86:

Amount

Tax effect

EPS impact

Description

Segment

Line item

(in millions)

(in millions)

(per share)

Foreign currency transaction gain (loss)

Consolidated

Foreign currency transaction gain (loss)

$

$

6

$

Unrealized gain (loss) on derivatives

Corporate and Other

Cost of goods sold

2

(2)

—

Closed and indefinitely idled facility costs

Phosphate

Other operating income (expense)

7

Ma'aden mark-to-market

Corporate and Other

Other non-operating income (expense)

7

ARO Adjustment

Phosphate/Potash

Other operating income (expense)

Environmental Reserve

Phosphate

Other operating income (expense)

8

Realized gain (loss) on RCRA Trust Securities

Phosphate

Other non-operating income (expense)

8

(2)

Net Gain on assets held for sale and transaction fees

Brazil/Corp

Other operating income (expense)/SG&A

Impairment of goodwill and asset write-offs

Brazil

Impairment of goodwill

Loss on assets held for sale

Potash

Loss (gain) on assets sold and to be sold

Brazil Valuation Adjustment

Brazil

(Provision for) benefit from income taxes

—

Total Notable Items

$

$

$

For the three months ended December 31, 2024, the Company reported the following notable items which, combined, positively impacted earnings per share by $0.08:

Amount

Tax effect

EPS impact

Description

Segment

Line item

(in millions)

(in millions)

(per share)

Foreign currency transaction gain (loss)

Consolidated

Foreign currency transaction gain (loss)

$

$

$

Unrealized gain (loss) on derivatives

Corporate and Other

Cost of goods sold

Closed and indefinitely idled facility costs

Phosphate

Other operating income (expense)

2

FX functional currency

Mosaic Fertilizantes

Cost of goods sold

9

(2)

Realized gain (loss) on RCRA Trust Securities

Phosphate

Other non-operating income (expense)

(5)

1

ARO Adjustment

Phosphate

Other operating income (expense)

4

Hurricane Milton idle costs

Phosphate

Cost of goods sold

Gain on sale of equity investment

Phosphate

Other non-operating income (expense)

Ma'aden mark-to-market

Corporate and Other

Other non-operating income (expense)

(5)

ARO Adjustment

Potash

Other operating income (expense)

7

(1)

Arbitration reserve

Phosphate

Other Operating Expense/Non Controlling Interest

9

Total Notable Items

$

$

$

Condensed Consolidated Statements of Earnings (Loss)

(in millions, except per share amounts)

The Mosaic Company

(unaudited)

Three months ended December 31,

Years ended

Net sales

$

$

$

$

Cost of goods sold

Gross margin

Selling, general and administrative expenses

Loss (gain) on assets sold and to be sold

—

—

Impairment of goodwill

—

—

Other operating expenses

Operating earnings (loss)

Interest expense, net

Foreign currency transaction gain (loss)

Gain on sale of equity investment

—

—

Other income (expense)

Earnings (loss) from consolidated companies before income taxes

Provision for income taxes

Earnings (loss) from consolidated companies

Equity in net earnings of nonconsolidated companies

Net earnings (loss) including noncontrolling interests

Less: Net earnings (loss) attributable to noncontrolling interests

Net earnings (loss) attributable to Mosaic

$

$

$

$

Diluted net earnings (loss) per share attributable to Mosaic

$

$

$

$

Diluted weighted average number of shares outstanding

Condensed Consolidated Balance Sheets

(in millions, except per share amounts)

The Mosaic Company

(unaudited)

Assets

Current assets:

Cash and cash equivalents

$

$

Receivables, net

Inventories

Assets held for sale

—

Other current assets

Total current assets

Property, plant and equipment, net

Equity securities and investments in nonconsolidated companies

Goodwill

Deferred income taxes

Other assets

Total assets

$

$

Liabilities and Equity

Current liabilities:

Short-term debt

$

$

Current maturities of long-term debt

Structured accounts payable arrangements

Accounts payable

Accrued liabilities

Liabilities held for sale

—

Total current liabilities

Long-term debt, less current maturities

Deferred income taxes

Other noncurrent liabilities

Equity:

Preferred stock, $0.01 par value, 15,000,000 shares authorized, none issued and outstanding as of December 31, 2025 and 2024

—

—

Common stock, $0.01 par value, 1,000,000,000 shares authorized, 395,125,254 shares issued and 317,408,647 shares outstanding as of December 31, 2025, 394,648,654 shares issued and 316,932,047 shares outstanding as of December 31, 2024

Capital in excess of par value

Retained earnings

Accumulated other comprehensive loss

Total Mosaic stockholders’ equity

Non-controlling interests

Total equity

Total liabilities and equity

$

$

Condensed Consolidated Statements of Cash Flows

(in millions, except per share amounts)

The Mosaic Company

(unaudited)

Three months ended December 31,

Years ended

Cash Flows from Operating Activities:

Net earnings including noncontrolling interests

$

$

$

$

Adjustments to reconcile net earnings including noncontrolling interests to net cash provided by operating activities:

Depreciation, depletion and amortization

Deferred and other income taxes

Equity in net (earnings) of nonconsolidated companies, net of dividends

Accretion expense for asset retirement obligations

Amortization of debt financing fees

Share-based compensation expense

Impairment of goodwill

—

—

Unrealized (gain) loss on derivatives

Foreign currency adjustments

Loss (gain) on assets sold and to be sold

—

—

Gain on sale of equity investment

—

—

Unrealized (gain) loss on equity securities

Other

Changes in assets and liabilities:

Receivables, net

Inventories, net

Other current assets and noncurrent assets

Accounts payable and accrued liabilities

Other noncurrent liabilities

Net cash provided by (used in) operating activities

Cash Flows from Investing Activities:

Capital expenditures

Purchases of available-for-sale securities - restricted

Proceeds from sale of available-for-sale securities - restricted

Proceeds from sale of assets

Other

Net cash used in investing activities

Cash Flows from Financing Activities:

Payments of short-term debt

Proceeds from issuance of short-term debt

Payments from inventory financing arrangement

Proceeds from inventory financing arrangement

Payments of structured accounts payable arrangements

Proceeds from structured accounts payable arrangements

Payments of long-term debt

Proceeds from issuance of long-term debt

Collections of transferred receivables

Payments of transferred receivables

Repurchases of stock

—

—

Cash dividends paid

Dividends paid to non-controlling interest

Other

Net cash provided by (used in) financing activities

Effect of exchange rate changes on cash

Net change in cash, cash equivalents and restricted cash

Cash, cash equivalents and restricted cash—beginning of year

Cash, cash equivalents and restricted cash—end of year

$

$

$

$

Years ended December 31,

Reconciliation of cash, cash equivalents and restricted cash reported within the consolidated balance sheets to the consolidated statements of cash flows:

Cash and cash equivalents

$

$

Restricted cash in other current assets

Restricted cash in other assets

Total cash, cash equivalents and restricted cash shown in the statement of cash flows

$

$

Reconciliation of Non-GAAP Financial Measures

Earnings Per Share Calculation

Three months ended

Years ended

Net earnings (loss) attributed to Mosaic

$

$

$

$

Basic weighted average number of shares outstanding

Dilutive impact of share-based awards

—

Diluted weighted average number of shares outstanding

Basic net earnings (loss) per share

$

$

$

$

Diluted net earnings (loss) per share

$

$

$

$

Notable items impact on earnings (loss) per share

$

$

$

$

Adjusted earnings per share

$

$

$

$

Reconciliation of Non-GAAP Financial Measures

Years ended

Net cash provided by operating activities

$

$

Capital expenditures

Free cash flow

$

$

Consolidated Earnings (in millions)

Three months ended

Year ended

Consolidated net earnings (loss) attributable to Mosaic

$

$

$

$

Less: Consolidated interest expense, net

Plus: Consolidated depreciation, depletion and amortization

Plus: Accretion expense

Plus: Share-based compensation expense

6

7

Plus: Consolidated provision for (benefit from) income taxes

Less: Equity in net earnings of nonconsolidated companies, net of dividends

—

9

—

Plus: Notable items not included above

Adjusted EBITDA

$

$

$

$

Income Tax Effective Tax Rate (in millions)

Year ended

Income Tax Expense

$

Earnings Before Tax

$

Effective Tax Rate

%

Income Tax Expense

$

Tax Discretes Excluding Notable

3

Tax Expense on All Other Notable Items (see notable items table for details of these items)

Adjusted Income Tax Expense

$

Earnings Before Tax

$

Earnings Impact of All Notable Items (net of non-controlling interest)

Adjusted Earnings Before Tax

$

Adjusted Effective Tax Rate

%

Reconciliation of Non-GAAP Financial Measures

Three months ended December 31,

Years ended December 31,

Potash Earnings (in millions)

Operating Earnings

$

$

$

$

Plus: Depreciation, Depletion and Amortization

Plus: Accretion Expense

3

2

9

Plus: Foreign Exchange Gain (Loss)

Plus: Other Non Operating Income

1

1

4

1

Plus: Notable Items

Adjusted EBITDA

$

$

$

$

Three months ended December 31,

Years ended December 31,

Phosphate Earnings (in millions)

Operating Earnings (Loss)

$

$

$

$

Plus: Depreciation, Depletion and Amortization

Plus: Accretion Expense

Plus: Foreign Exchange Gain (Loss)

(3)

(4)

(3)

(5)

Plus: Other Non Operating Income (Expense)

5

(7)

Plus: Dividends from equity investments

—

—

—

Less: Earnings (Loss) from Consolidated Noncontrolling Interests

—

(4)

Plus: Notable Items

Adjusted EBITDA

$

$

$

$

Three months ended December 31,

Years ended December 31,

Mosaic Fertilizantes (in millions)

Operating Earnings (Loss)

$

$

$

$

Plus: Depreciation, Depletion and Amortization

Plus: Accretion Expense

4

4

Plus: Foreign Exchange Gain (Loss)

Plus: Other Non Operating Income (Expense)

(2)

(2)

(5)

(8)

Less: Earnings (Loss) from Consolidated Noncontrolling Interests

1

1

2

1

Plus: Notable Items

Adjusted EBITDA

$

$

$

$

Reconciliation of Non-GAAP Financial Measures

Three months ended December 31,

Years ended December 31,

Corporate and Other Earnings (in millions)

Operating Earnings (Loss)

$

$

$

$

Plus: Depreciation, Depletion and Amortization

9

7

Plus: Accretion Expense

6

7

Plus: Foreign Exchange Gain (Loss)

Plus: Other Income (Expense)

Plus: Earnings (Loss) from Equity Investments

—

—

2

—

Less: Earnings (Loss) from Consolidated Noncontrolling Interests

—

(1)

2

(2)

Plus: Notable Items

Adjusted EBITDA

$

$

$

$

Reconciliation of Non-GAAP Financial Measures

Three months ended December 31,

Years ended December 31,

Potash

Total COGS

$

$

$

$

Depreciation & accretion expense

Canadian Resource Taxes

Change in Inventory

(1)

(2)

Non-MOP Production Costs

Total MOP Cash Costs

$

$

$

$

Production tonnes (thousands)

MOP Cash Costs of Production per production tonne

$

$

$

$

Phosphate

Total COGS

$

$

$

$

Depreciation & accretion expense

Miski Mayo costs

Change in Inventory

Non Production Costs

Cash cost of U.S. Mined Rock

U.S. Rock Production tonnes (thousands)

Cash costs of U.S. mined rock/production tonne

$

$

$

$

Phosphate cash costs of conversion

$

$

$

$

Production tonnes (thousands)

Phosphate cash costs of conversion per production tonne

$

$

$

$

Fertilizantes

Total COGS

$

$

$

$

Distribution product costs

Depreciation & accretion expense

Change in Inventory

Non Production Costs

Rock cash costs of production

Potash cash costs of production

8

Production tonnes (thousands)

Potash cash costs of production per production tonne

$

$

$

$

Phosphate cash costs of conversion

$

$

$

$

Production tonnes (thousands)

Phosphate cash costs of conversion per production tonne

$

$

$

$